Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep 27:35:76-81.
doi: 10.1016/j.amsu.2018.09.037. eCollection 2018 Nov.

Experimental comparative study of thrombogenicity of two differently luminal heparinized ePTFE vascular prosthetics

Mads Liisberg  1   2 , Michael Stenger  1   2 , Carsten Behr-Rasmussen  3 , Jane Stubbe  2   4 , Jes S Lindholt  1   2   3
Affiliations

Experimental comparative study of thrombogenicity of two differently luminal heparinized ePTFE vascular prosthetics

Mads Liisberg et al. Ann Med Surg (Lond). .

Abstract

Introduction: ; Heparin bonded grafts have proven to improve patency, at least transiently.Two different heparin bonded expanded polytetrafluoroethylene (ePTFE) grafts produced by different technologies are currently available.This pilot primary goal was to test these commonly used, but differently heparinized ePTFE grafts for differences in primary patency after a 6-months follow-up in a sheep model. Secondly, the aim was to establish a large animal model to enable future translational studies and further graft development.

Method: ; End-to-side bypass of the common carotid artery was performed bilaterally in sheep. Either a Gore® Propaten heparinized graft or a Jotec® Flowline Bipore heparinized graft was used, both 5 mm in diameter.Following graft implantation, the sheep were kept on pasture for 6 months, with monthly duplex scans to determine patency. At termination, the grafts were duplex scanned a final time, with the animals sedated, and the grafts were removed for heparin activity analysis.

Results: ; 14 sheep were operated, 11 survived total follow-up time. At final follow-up, 4 patent Gore® grafts, and 6 Jotec® remained. Mean patency time was 106.7 ± 21.9(SD) days and 96.2 ± 25.9(SD) days for Gore® and Jotec®, respectively. Log-rank test showed no significant difference at final follow-up after 6 months. Post mortem heparin analysis showed no significant difference in mean activity.

Conclusion: ; Based on patency data alone, no significant difference between these grafts were found. In accordance, heparin activity analysis showed no difference between the grafts. The model itself, proved easily implementable, and provides many possibilities for future studies, though some adjustments should be made to improve survival.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Preparation of the common carotid artery. A; Common Carotid Artery V; Jugular vein.
Fig. 2
Fig. 2
Final position of Gore® graft, palpable pulse control of patency before wound closure.
Fig. 3
Fig. 3
Duplex-scan of sheep.
Fig. 4
Fig. 4
Open graft, no turbulent flow or signs of thrombosis.
Fig. 5
Fig. 5
Occluded graft, no color signal. Mural thrombosis is clearly visible. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
Fig. 6
Fig. 6
Kaplan-Meier survival plot of Gore® and Jotec® Grafts. Log-rank p = 0.88 at end-point.
See this image and copyright information in PMC

References

    1. Daenens K., Schepers S., Fourneau I., Houthoofd S., Nevelsteen A. Heparin-bonded ePTFE grafts compared with vein grafts in femoropopliteal and femorocrural bypasses: 1- and 2-year results. J. Vasc. Surg. 2009;49(5):1210–1216. - PubMed
    1. Heyligers J.M., Verhagen H.J., Rotmans J.I., Weeterings C., de Groot P.G., Moll F.L. Heparin immobilization reduces thrombogenicity of small-caliber expanded polytetrafluoroethylene grafts. J. Vasc. Surg. 2006;43(3):587–591. - PubMed
    1. Lammer J., Zeller T., Hausegger K.A., Schaefer P.J., Gschwendtner M., Mueller-Huelsbeck S. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease) J. Am. Coll. Cardiol. 2013;62(15):1320–1327. - PubMed
    1. Peeters P., Verbist J., Deloose K., Bosiers M. Results with heparin bonded polytetrafluoroethylene grafts for femorodistal bypasses. J. Cardiovasc. Surg. 2006;47(4):407–413. - PubMed
    1. Pulli R., Dorigo W., Castelli P., Dorrucci V., Ferilli F., De Blasis G. Midterm results from a multicenter registry on the treatment of infrainguinal critical limb ischemia using a heparin-bonded ePTFE graft. J. Vasc. Surg. 2010;51(5) 1167-11677 e1. - PubMed